by telrheum | Jun 24, 2024 | Biologic Therapy, Anti-TNF, IL-23 Inhibitors, Il-6 inhibitors, JAK Inhibitor, Rituximab
Background: Rheumatoid arthritis (RA) patients often face higher cardiovascular risks due to chronic inflammation. Biologic disease-modifying antirheumatic drugs (biologic drugs) help control this inflammation, especially in those who don’t respond well to...
by telrheum | Jun 21, 2024 | Biologic Therapy, Anti-TNF, Spondyloarthritis
This study investigated why some children with juvenile spondyloarthritis (JSpA) do not respond to TNF inhibitors (TNFi), a common treatment. Researchers analyzed data from patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA)...
